XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Revenue $ 31,080 $ 31,617
Costs and expenses:    
Cost of product revenue 14,778 15,623
Research and development 17,417 15,063
Selling, general and administrative 36,355 26,799
Total costs and expenses 68,550 57,485
Loss from operations (37,470) (25,868)
Other income (expense):    
Interest income 151 118
Interest expense (1,883) (1,870)
Other income (expense), net (217) (32)
Total other expense, net (1,949) (1,784)
Net loss before provision for income tax (39,419) (27,652)
Provision for income tax (81) (60)
Net loss $ (39,500) $ (27,712)
Net loss per share - basic (in dollars per share) $ (0.86) $ (0.62)
Net loss per share - diluted (in dollars per share) $ (0.86) $ (0.62)
Weighted average shares used in computing basic net loss per share (in shares) 45,998 44,669
Weighted average shares used in computing diluted net loss per share (in shares) 45,998 44,669
Total product and service revenue    
Revenue:    
Revenue $ 30,841 $ 31,394
Product    
Revenue:    
Revenue 26,571 27,708
Costs and expenses:    
Cost of product revenue 11,472 12,046
Service revenue    
Revenue:    
Revenue 4,270 3,686
Costs and expenses:    
Cost of product revenue 3,306 3,577
Collaboration revenue    
Revenue:    
Revenue $ 239 $ 223